Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-11-06
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed

Amends S100WFZ4. Amended by S100WZC4 (2025-11-06).

Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.73T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Revenue¥3.15T2024-01-01 → 2024-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.57T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Operating income¥479.9bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Operating income¥432.7bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Profit before tax¥437.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Profit before tax¥233.8bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥399.1bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥319.9bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥179.2bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥305.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥322.0bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Net income¥182.6bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥307.1bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Total assets¥8.26Tat 2025-06-30Cons.Assets IFRS
Total assets¥8.37Tat 2024-12-31Cons.Assets IFRS
Total assets¥7.87Tat 2024-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥4.12Tat 2025-06-30Cons.Liabilities IFRS
Total liabilities¥4.52Tat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥4.14Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥3.85Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥4.53Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥4.06Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.77Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥865.2bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.08Tat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.09Tat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥167.5bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥630.0bn2024-01-01 → 2024-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥260.2bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥132.0bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥439.8bn2024-01-01 → 2024-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥28.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥230.9bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥94.9bn2024-01-01 → 2024-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥267.5bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥180.192025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥100.952024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥171.892024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥180.172025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥100.942024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥171.862024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.1%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.0%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio56.4%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥686m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.9bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥1.9bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥1.9bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥48.3bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥48.3bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥4.2bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥4.2bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30−¥20.2bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue2025-01-01 → 2025-06-30¥76.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue external2025-01-01 → 2025-06-30¥76.7bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥14m
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.6bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.6bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥3.0bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue2025-01-01 → 2025-06-30¥1.61T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue external2025-01-01 → 2025-06-30¥1.61T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥0
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥556.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥556.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥520.9bn
—segment totalrevenue2025-01-01 → 2025-06-30¥1.73T
—segment totalrevenue external2025-01-01 → 2025-06-30¥1.73T
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥14m
—segment totalsegment profit2025-01-01 → 2025-06-30¥562.9bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥562.9bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥503.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥658m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥27.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥27.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥25.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥1.7bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥44.1bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥44.1bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-06-30¥73.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-06-30¥73.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥13m
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.4bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.4bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.3bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-06-30¥1.45T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-06-30¥1.45T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥182m
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥472.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥472.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥449.6bn
—segment totalrevenue2024-01-01 → 2024-06-30¥1.57T
—segment totalrevenue external2024-01-01 → 2024-06-30¥1.57T
—segment totalrevenue intersegment2024-01-01 → 2024-06-30¥196m
—segment totalsegment profit2024-01-01 → 2024-06-30¥480.5bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥480.5bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥458.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 980
ItemContextValueUnit
Capital contribution from non controlling interests fin cf IFRSPrior1YTDDuration108000000JPY
Capital contribution from non controlling interests fin cf IFRSCurrentYTDDuration-JPY
Increase decrease in short term borrowings and commercial paper fin cf IFRSPrior1YTDDuration-159982000000JPY
Increase decrease in short term borrowings and commercial paper fin cf IFRSCurrentYTDDuration9973000000JPY
Proceeds from long term borrowings fin cf IFRSPrior1YTDDuration202000000JPY
Proceeds from long term borrowings fin cf IFRSCurrentYTDDuration99437000000JPY
Repayments of long term borrowings fin cf IFRSPrior1YTDDuration-4492000000JPY
Repayments of long term borrowings fin cf IFRSCurrentYTDDuration-666593000000JPY
Proceeds from issuance of bonds fin cf IFRSPrior1YTDDuration97616000000JPY
Proceeds from issuance of bonds fin cf IFRSCurrentYTDDuration515001000000JPY
Redemption of bonds fin cf IFRSPrior1YTDDuration-8397000000JPY
Redemption of bonds fin cf IFRSCurrentYTDDuration-JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-13427000000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-12916000000JPY
Payments for purchase of treasury shares fin cf IFRSPrior1YTDDuration-1000000JPY
Payments for purchase of treasury shares fin cf IFRSCurrentYTDDuration-1579000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YTDDuration-99000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYTDDuration-5000000JPY
Other fin cf IFRSPrior1YTDDuration0JPY
Other fin cf IFRSCurrentYTDDuration0JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-267492000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-230877000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSPrior1YTDDuration-35986000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSCurrentYTDDuration-195391000000JPY
Cash and cash equivalents IFRSPrior2YearInstant1040206000000JPY
Cash and cash equivalents IFRSPrior1YearInstant1084567000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration83620000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration-3153000000JPY
Changes in cash and cash equivalents resulting from transfer to assets held for sale IFRSPrior1YTDDuration-JPY
Changes in cash and cash equivalents resulting from transfer to assets held for sale IFRSCurrentYTDDuration-20837000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant1087840000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant865185000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember1451360000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember44059000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember73815000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember1569235000000JPY
Revenue from external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember658000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenue from external customers IFRSPrior1YTDDuration1569892000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember182000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember-JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember13000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember196000000JPY
Intersegment revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1508000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-1703000000JPY
Intersegment revenue IFRSPrior1YTDDuration-JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember1451542000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember44059000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember73829000000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember1569430000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass